Cargando…
Lymphoma immunotherapy: Efficacy, safety and accessibility to CAR-T therapy for lymphomas
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925561/ http://dx.doi.org/10.1097/HS9.0000000000000092 |
| _version_ | 1784670084328849408 |
|---|---|
| author | Borchmann, Peter |
| author_facet | Borchmann, Peter |
| author_sort | Borchmann, Peter |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8925561 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Wolters Kluwer Health |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89255612022-03-18 Lymphoma immunotherapy: Efficacy, safety and accessibility to CAR-T therapy for lymphomas Borchmann, Peter Hemasphere EHA23 Educational Updates in Hematology Book Wolters Kluwer Health 2018-06-11 /pmc/articles/PMC8925561/ http://dx.doi.org/10.1097/HS9.0000000000000092 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CCBY-NC-ND), which allows third parties to download the abstracts and share them with others as long as they credit the author and the abstract book, but they cannot change the content in any way or use them commercially. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | EHA23 Educational Updates in Hematology Book Borchmann, Peter Lymphoma immunotherapy: Efficacy, safety and accessibility to CAR-T therapy for lymphomas |
| title | Lymphoma immunotherapy: Efficacy, safety and accessibility to CAR-T therapy for lymphomas |
| title_full | Lymphoma immunotherapy: Efficacy, safety and accessibility to CAR-T therapy for lymphomas |
| title_fullStr | Lymphoma immunotherapy: Efficacy, safety and accessibility to CAR-T therapy for lymphomas |
| title_full_unstemmed | Lymphoma immunotherapy: Efficacy, safety and accessibility to CAR-T therapy for lymphomas |
| title_short | Lymphoma immunotherapy: Efficacy, safety and accessibility to CAR-T therapy for lymphomas |
| title_sort | lymphoma immunotherapy: efficacy, safety and accessibility to car-t therapy for lymphomas |
| topic | EHA23 Educational Updates in Hematology Book |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925561/ http://dx.doi.org/10.1097/HS9.0000000000000092 |
| work_keys_str_mv | AT borchmannpeter lymphomaimmunotherapyefficacysafetyandaccessibilitytocarttherapyforlymphomas |